Royal Philips acquires the U.K.’s Remote Diagnostic Technologies for undisclosed price

Royal Philips acquired Remote Diagnostic Technologies, the maker of resuscitation and emergency care devices, for an undisclosed price. (Philips/RDT)

Royal Philips acquired Remote Diagnostic Technologies for an undisclosed price in a deal set to expand the Amsterdam-based electronics giant’s position in the resuscitation and emergency care market.

Details of the acquisition weren’t disclosed, the company said, though it estimates the resuscitation and emergency care arena to be about  $1.6 billion.

Remote Diagnostics (RDT), which was founded in 1997 and employs about 100 people, focuses on prehospital acute care, including primary patient stabilization, at the scene medical treatment, and transportation to hospitals.

CONFERENCE

AI Innovations for Life Science and Healthcare Summit East

Join the expert speaking faculty of over 30 life science, healthcare, and tech professionals on June 13–14, 2019, in Philadelphia, as we elevate clinical trial operations, healthcare outcomes, and supply chain implementation through AI. Use Discount Code 796819FIERCE to save 15% off the standard registration rate.

"With its focus on the pre-hospital market, RDT’s portfolio of emergency care solutions will enable Philips to grow its presence in this market, as we further build our health technology portfolio and extend the range of connected, data-driven solutions we offer to our customers,” Arman Voskerchyan, head of Philips’ Therapeutic Care unit, said in a statement.

With the deal, Philips will get RDT’s products designed for ambulance and emergency responders that includes the Tempus ALS, a modularized monitor and defibrillator that is a smaller, lighter and more flexible package. RDT also offers other lightweight monitors equipped with telecommunication capabilities for various emergency responders.

Earlier this month, Philips bought EPD Solutions in a deal that could be worth up to $539 million—$293 million upfront and a possible additional $246.2 million if certain milestones are reached. California-based EPD makes cardiac imaging and navigation systems designed to aid electrophysiologists in navigating the heart through a detailed 3D image of the cardiac anatomy.

Suggested Articles

TytoCare is pairing up with big-box electronics retailer Best Buy to put its remote medical exam hardware directly into the hands of consumers.

PerkinElmer signed on to Accenture’s life science ecosystem to integrate its tech into the cloud-based platform’s drug discovery efforts.

To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding.